GT
AGN

Greenleaf Trust’s Allergan plc AGN Stock Holding History

Greenleaf Trust’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-4,114
Closed -$729K – 603
2020
Q1 		$729K Buy
4,114
+508
+14% +$95.7K 0.01% 169
2019
Q4 		$689K Buy
3,606
+255
+8% +$46K 0.01% 224
2019
Q3 		$564K Buy
3,351
+947
+39% +$154K 0.01% 258
2019
Q2 		$403K Buy
2,404
+55
+2% +$7.62K 0.01% 332
2019
Q1 		$344K Buy
2,349
+384
+20% +$55.7K 0.01% 354
2018
Q4 		$263K Sell
1,965
-1,327
-40% -$218K 0.01% 386
2018
Q3 		$627K Buy
3,292
+671
+26% +$123K 0.01% 243
2018
Q2 		$437K Buy
2,621
+617
+31% +$99.1K 0.01% 301
2018
Q1 		$337K Buy
2,004
+246
+14% +$41.3K 0.01% 307
2017
Q4 		$288K Buy
1,758
+229
+15% +$41.1K 0.01% 347
2017
Q3 		$313K Sell
1,529
-539
-26% -$125K 0.01% 302
2017
Q2 		$503K Sell
2,068
-45
-2% -$10.6K 0.01% 196
2017
Q1 		$505K Sell
2,113
-524
-20% -$122K 0.01% 157
2016
Q4 		$554K Buy
2,637
+1,671
+173% +$346K 0.01% 128
2016
Q3 		$222K Buy
+966
New +$236K 0.01% 188

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $5.64B AUM 18.33% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Greenleaf Trust's AGN Position: Q2 2020 in Review

Greenleaf Trust sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 4,114 shares — an estimated $729K sold.

Greenleaf Trust first reported a position in AGN in Q3 2016 and held it in 15 quarters. The position peaked at $729K in Q1 2020. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Greenleaf Trust reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Greenleaf Trust sold 4,114 Allergan plc shares in Q2 2020, an estimated $729K.
  • Greenleaf Trust first reported a position in Allergan plc in Q3 2016 and held it in 15 quarters.
  • Greenleaf Trust's Allergan plc position peaked at $729K in Q1 2020.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Greenleaf Trust's 13F filing for Q2 2020, filed 12 Aug 2020.